Simsen Diagnostics is a biotech company focusing on transforming cancer monitoring. The core is a cutting-edge ultrasensitive technology designed to detect tumor DNA from simple blood samples. The flagship solution, Simsen Personal, offers a patient-specific test capable of identifying cancer years before standard-of-care tools. Established in 2020 as a research spin-out from Sahlgrenska Academy, Simsen Diagnostics has achieved consistent growth, earning recognition from the pharmaceutical industry. Located within the BioVentureHub at AstraZeneca Gothenburg, the company leads the way in offering innovative solutions for cancer monitoring.
